Cargando…
Protocol for In Vivo Evaluation and Use of Destabilizing Domains in the Eye, Liver, and Beyond
Destabilizing domains (DDs) have been used successfully to conditionally control the abundance of proteins of interest (POIs) in a small-molecule-dependent manner in mice, worms (Caenorhabditis elegans), and Drosophila. However, development of such systems must account for delivery of the DD-POIs to...
Autores principales: | Ramadurgum, Prerana, Daniel, Steffi, Hulleman, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521670/ https://www.ncbi.nlm.nih.gov/pubmed/32995756 http://dx.doi.org/10.1016/j.xpro.2020.100094 |
Ejemplares similares
-
Protocol for Designing Small-Molecule-Regulated Destabilizing Domains for In Vitro Use
por: Ramadurgum, Prerana, et al.
Publicado: (2020) -
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging
por: Peng, Hui, et al.
Publicado: (2022) -
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo
por: Peng, Hui, et al.
Publicado: (2019) -
A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye – Implications for Ocular Gene Therapy
por: Datta, Shyamtanu, et al.
Publicado: (2018) -
Augmenting the Referral Pathway for Retinal Services Among Patients With Diabetes Mellitus at Reiyukai Eiko Masunaga Eye Hospital, Nepal: Protocol for a Nonrandomized, Pre–Post Intervention Study
por: Shrestha, Ruchi, et al.
Publicado: (2021)